ERNA vs PPL · P/E 0.0, rev $582.0K vs P/E 22, rev $8.46B
Eterna Therapeutics Inc (ERNA) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the ERNA and PPL stock pages for the full models.
Not investment advice.